Font: Financial Modeling Prep • Jun 30, 2026
AeroVironment (NASDAQ:AVAV), a leading technology firm specializing in the design and manufacture of unmanned aircraft systems (UAS) and advanced drone technology, received a confirmed "Outperform" rating from RBC Capital on June 30, 2026. This positive investment rating indicates the analyst's belief that the stock will outperform the broader market. However, RBC Capital also adjusted its stock price target downward from $250.00 to $210.00.
The "Outperform" rating is underpinned by AeroVironment's robust financial performance. As reported by CNBC, the company announced impressive fourth-quarter earnings of $1.84 per share, significantly surpassing the analyst estimate of $1.46. Furthermore, its revenue demonstrated substantial growth, more than doubling to $641.62 million from $275.10 million in the prior year's comparable period, a key financial highlight also noted by WSJ.
Looking ahead, AeroVironment's future revenue outlook appears strong, bolstered by a significant increase in its funded backlog. The company's funded backlog, representing the total value of confirmed orders yet to be fulfilled, grew by 65% to $1.20 billion. This substantial growth in confirmed orders underscores the high market demand for AeroVironment's diverse product portfolio, which includes advanced drones, counter-drone systems, and innovative space technology solutions.
The adjustment to the stock price target likely reflects recent challenges faced by AeroVironment. PR Newswire reported the filing of a securities fraud class action lawsuit against the company. This legal action alleges that AeroVironment misled investors regarding its SCAR contract. Following the announcement of the lawsuit, AeroVironment's stock price experienced a sharp decline of over 17%, signaling significant investor concern and market reaction to these serious allegations.
At the time of the rating update, AeroVironment's stock price stood at $139.00 per share. This current stock valuation is notably below the newly set $210.00 target price. The company currently holds a market capitalization of approximately $6.94 billion, and its stock has demonstrated considerable volatility, trading between a 52-week low of $135.20 and a 52-week high of $417.86 over the past year.
|
LIMN§>
Liminatus Pharma, Inc. Class A Common Stock
|
$0.15
29.00%
|
|
BITO§>
ProShares Bitcoin ETF
|
$8.72
-0.94%
|
|
AAL§>
American Airlines Group Inc.
|
$15.60
-0.19%
|
|
NU§>
Nu Holdings Ltd.
|
$13.79
-0.65%
|
|
ATAI§>
Atai Beckley Inc.
|
$7.15
33.40%
|
|
EOSER§>
Eos Energy Enterprises Inc. Rt
|
$0.03
-3.08%
|
|
OPEN§>
Opendoor Technologies Inc.
|
$4.57
-3.79%
|
|
NOK§>
Nokia Oyj
|
$10.38
-7.78%
|
|
TGHL§>
Growhub Ltd
|
$1.52
86.62%
|
|
IQST§>
iQSTEL Inc.
|
$1.22
38.45%
|